Expertise and rankings

  • Kidney cancer experts. Mayo Clinic's experienced specialists in urology, medical oncology, radiation oncology, radiology and kidney pathology work as a team to provide the best care for people with kidney cancer. Our highly skilled urologic surgeons have perfected minimally invasive techniques in partial nephrectomy (kidney-sparing surgery) and complete nephrectomy (kidney removal) to remove kidney cancer and preserve function as much as possible.
  • Excellent outcomes. Mayo's multispecialty team approach ensures that each patient receives the highest quality of care and the best outcome. Mayo Clinic offers low nephrectomy complication rates with short hospital stays. Mayo's urologic surgeons showed early on that, in appropriately selected kidney cancer cases, partial nephrectomy outcome can be just as good as radical nephrectomy. Partial nephrectomy preserves kidney function and aids in prevention of complications.
  • Expertise in complex cases. Mayo Clinic urologic surgeons and medical oncologists are seasoned experts in treating even the most advanced cases of kidney cancer, including complex large renal masses. Mayo’s highly specialized and experienced surgical teams can perform complex nephrectomies in circumstances where others may view the tumor as not removable.
  • Comprehensive cancer center. Mayo Clinic Cancer Center meets strict standards for a National Cancer Institute comprehensive cancer center, recognizing excellence in diagnosis, treatment, prevention and research. In addition, Mayo Clinic is designated as a National Comprehensive Cancer Network center and is a member of the Children's Oncology Group, collaborating with experts in childhood cancer around the world.
  • Personalized medicine. Mayo's kidney cancer team tailors treatment to the specific needs of the patient. The Mayo Clinic Center for Individualized Medicine offers genomic testing to select patients in order to personalize care for difficult medical problems. Patient requests are assessed and considered on a case-by-case basis.
  • Genetic testing and counseling. If hereditary cancer syndromes or other hereditary disorders such as von Hippel-Lindau disease are known or suspected, Mayo Clinic's medical geneticists and certified genetics counselors work as a team to provide genetic testing and counseling.

If a genetic condition is suspected, medical geneticists and certified genetic counselors at Mayo Clinic evaluate genetic conditions and provide testing, education and counseling.

Aug. 15, 2017
References
  1. NCCN Guidelines Version 2.2017: Kidney cancer. National Comprehensive Cancer Network. 2016.
  2. Atkins MG. Clinical manifestations, evaluation, and staging of renal cell carcinoma. http://www.uptodate.com/home. Accessed Feb. 8, 2017.
  3. American Cancer Society. What is kidney cancer? https://www.cancer.org/cancer/kidney-cancer/about/what-is-kidney-cancer.html. Accessed Feb. 8, 2017.
  4. American Cancer Society. Causes, risk factors, and prevention. https://www.cancer.org/cancer/kidney-cancer/causes-risks-prevention.html. Accessed Feb 8, 2017.
  5. Ho TH, et al. Genetic kidney cancer syndromes. Journal of the National Comprehensive Cancer Network. 2014;12:1347.
  6. Fay AP, et al. Whole-exome sequencing in two extreme phenotypes of response to VEGF-targeted therapies in patients with metastatic clear cell renal carcinoma. Journal of the National Comprehensive Cancer Network. 2016;14:820.
  7. Drugs approved for kidney (renal cell) cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/drugs/kidney. Accessed Feb. 8, 2017.
  8. Kardos SV, et al. Association of type of renal surgery and access to robotic technology for kidney cancer: Results from a population-based cohort. BJU International. 2014;114:549.
  9. George S, et al. Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression: A subgroup analysis of a randomized clinical trial. JAMA Oncology. 2016;2:1179.
  10. Atkins MG. Overview of the treatment of renal cell carcinoma. http://www.uptodate.com/home. Accessed Feb. 8, 2017.
  11. American Cancer Society. What are the key statistics about kidney cancer? https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html. Accessed Feb. 8, 2017.
  12. American Cancer Society. Kidney cancer: Early detection, diagnosis, and staging. https://www.cancer.org/cancer/kidney-cancer/detection-diagnosis-staging.html. Accessed Feb. 8, 2017.
  13. American Cancer Society. Treating kidney cancer. https://www.cancer.org/cancer/kidney-cancer/treating.html. Accessed Feb. 8, 2017.
  14. Ho, TH (expert answer). Mayo Clinic, Phoenix, Ariz. Feb. 11, 2017.
  15. National Institutes of Health. NIH clinical research trials and you. https://www.nih.gov/health-information/nih-clinical-research-trials-you. Accessed March 13, 2017.
  16. Leibovich, BC (expert answer). Mayo Clinic, Rochester, Minn. May 30, 2017.
  17. Richie JP, et al. Role of surgery in patients with metastatic renal cell carcinoma. http://www.uptodate.com/home. Accessed March 16, 2017.